Moreover, the data retrieved from cBio database [36, 37] revealed the presence of copy number loss of CHD5 in ccRCC [31], papillary RCC (TCGA) and prostate cancer [35, 38, 39] (Supplementary Figure 2). Here, CHD5 is linked to prostate cancer.